Top News

RuiYi Gets $4M In Venture Loan

La Jolla- and Shanghai-based RuiYi, a biopharmaceuticals firm developing treatments for rheumatoid arthritis and cancer, said yesterday that it has raised $4M in a venture debt funding, from Silicon Valley Bank. The company said it will use the funds to advance a pipeline of novel monoclonal antibodies (mAb) targeting G protein coupled receptors (GPCRs). RuiYi, which is led by Paul Grayson, has its operations split between the San Diego area and Shanghai.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel